Expression of tumour-specific antigens underlies cancer immunoediting
Cancer immunoediting is a process by which immune cells, particularly lymphocytes of the adaptive immune system, protect the host from the development of cancer and alter tumour progression by driving the outgrowth of tumour cells with decreased sensitivity to immune attack1, 2. Carcinogen-induced m...
Main Authors: | DuPage, Michel J., Mazumdar, Claire, Schmidt, Leah Marie, Cheung, Ann, Jacks, Tyler E. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2012
|
Online Access: | http://hdl.handle.net/1721.1/73483 https://orcid.org/0000-0001-5785-8911 https://orcid.org/0000-0001-9076-8475 |
Similar Items
-
Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor Progression
by: DuPage, Michel J., et al.
Published: (2014) -
MHC-II neoantigens shape tumour immunity and response to immunotherapy
by: Luoma, Adrienne M., et al.
Published: (2020) -
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
by: DuPage, Michel J., et al.
Published: (2016) -
Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
by: Arta Monir Monjazeb, et al.
Published: (2013-07-01) -
Gene essentiality for tumour growth influences neoantigen‐directed immunoediting
by: Hyoeun Bang, et al.
Published: (2022-01-01)